甘氨酸与多囊卵巢综合征发病机制的相关性研究

Abstract
Figure/Table
References
Related Citation (2)

Download: PDF (3613 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the association between glycine and the pathogenesis of PCOS. Methods Glycine levels were detected and correlation analysis was performed in 11 PCOS patients and 11 healthy women. Mouse models were constructed and divided into Ctrl group, Gly group, PCOS group, and PCOS+Gly group. Estrous cycle and ovarian morphology were observed. Sex hormone and lipid metabolism indicators were detected. RT qPCR was used to detect the mRNA levels of hormone synthase and sex hormone receptor in ovarian tissues. Results (1) Serum glycine levels in PCOS patients were decreased compared to the control group and the values of FAI, LH and LH/FSH levels in PCOS patients were increased, while SHBG were decreased. In the total sample population, glycine levels were positively correlated with SHBG and negatively correlated with FAI and LH/FSH ratio. Glycine reduced body weight and TC and LDL-C levels of PCOS mice. It also accelerated the recovery of estrus cycle, reduced the number of cystic follicles and hemorrhagic cysts, and downregulated the mRNA levels of CYP17A1, CYP19A1, FSHR, and LHR. Conclusion Serum glycine levels were positively correlated with SHBG, and negatively correlated with FAI and LH/FSH ratio. PCOS patients exhibited a decrease in glycine levels. Glycine improved the disorder of lipid metabolism in PCOS mice, restored normal estrus cycle, protected normal ovarian morphology and regulated sex hormone levels. Glycine may inhibit the occurrence and development of PCOS by regulating the expression of genes related to hormone synthesis.

Key words： glycine polycystic ovary syndrome estrous cycle sex hormone sex hormone receptor

Received: 25 March 2024

PACS:	R588
	R363

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MA Yu
	CHEN Wenxin
	WU Wei
	XU Boqun

Cite this article:

MA Yu,CHEN Wenxin,WU Wei等. Correlation between glycine and the pathogenesis of polycystic ovary syndrome[J]. HuNan ShiFan DaXue XueBao(YiXueBan), 2024, 21(3): 7-15.

URL:

http://yxb.hunnu.edu.cn/EN/ OR http://yxb.hunnu.edu.cn/EN/Y2024/V21/I3/7

[1] WITCHEL S F, OBERFIELD S E, PENA A S.Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls[J]. J Endocr Soc, 2019, 3(8) : 1545-1573.
[2] YANG J, CHEN C.Hormonal changes in PCOS[J]. J Endocrinol, 2024, 261(1) e230342.
[3] EL H M, PEREZ I, ZAMORA J, et al.Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats[J]. Am J Physiol Regul Integr Comp Physiol, 2004, 287(6) : R1387-R1393.
[4] GAO L, ZHANG C, ZHENG Y, et al. Glycine regulates lipid peroxidation promoting porcine oocyte maturation and early embryonic development[J]. J Anim Sci, 2023, 101: Skac 425.
[5] KURDI C, LELOVICS V, HESSZENBERGER D, et al.Amino Acid Profiling of Follicular Fluid in Assisted Reproduction Reveals Important Roles of Several Amino Acids in Patients with Insulin Resistance[J]. Int J Mol Sci, 2023, 24(15): 12458 .
[6] GAO L, ZHANG C, YU S, et al.Glycine ameliorates MBP-induced meiotic abnormalities and apoptosis by regulating mitochondrial-endoplasmic reticulum interactions in porcine oocytes[J]. Environ Pollut, 2022, 309: 119756.
[7] YUE J T, MIGHIU P I, NAPLES M, et al.Glycine normalizes hepatic triglyceride-rich VLDL secretion by triggering the CNS in high-fat fed rats[J]. Circ Res, 2012, 110(10) : 1345-1354.
[8] LI S, GUO Q, WANG Y M, et al.Glycine treatment enhances developmental potential of porcine oocytes and early embryos by inhibiting apoptosis[J]. J Anim Sci, 2018, 96(6) : 2427-2437.
[9] HART R.PCOS and infertility[J]. Panminerva Med, 2008, 50(4) : 305-314.
[10] HEIJBOER A C, HANNEMA S E.Androgen Excess and Deficiency: Analytical and Diagnostic Approaches[J]. Clin Chem, 2023, 69(12) : 1361-1373.
[11] PATEL K K, KASHFI K.Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs[J]. Biochem Pharmacol, 2022, 196: 114654.
[12] SIDDIQUI S, MATEEN S, AHMAD R, et al.A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)[J]. J Assist Reprod Genet, 2022, 39(11) : 2439-2473.
[13] INOUE S.Neural basis for estrous cycle-dependent control of female behaviors[J]. Neurosci Res, 2022, 176: 1-8.
[14] NIMZ M, SPITSCHAK M, FURBASS R, et al.The pre-ovulatory luteinizing hormone surge is followed by down-regulation of CYP19A1, HSD3B1, and CYP17A1 and chromatin condensation of the corresponding promoters in bovine follicles[J]. Mol Reprod Dev, 2010, 77(12): 1040-1048.
[15] VAN ROOYEN D, YADAV R, SCOTT E E, et al.CYP17A1 exhibits 17alphahydroxylase/17, 20-lyase activity towards 11beta-hydroxyprogesterone and 11-ketoprogesterone metabolites in the C11-oxy backdoor pathway[J]. J Steroid Biochem Mol Biol, 2020, 199: 105614.
[16] XU H, ZHANG X, YE Y, et al.Bisphenol A affects estradiol metabolism by targeting CYP1A1 and CYP19A1 in human placental JEG-3 cells[J]. Toxicol in Vitro, 2019, 61: 104615.
[17] GEORGE J W, DILLE E A, HECKERT L L.Current concepts of follicle-stimulating hormone receptor gene regulation[J]. Biol Reprod, 2011, 84(1) : 7-17.
[18] DEWAILLY D, ROBIN G, PEIGNE M, et al.Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary[J]. Hum Reprod Update, 2016, 22(6) : 709-724.
[19] EDSON M A, NAGARAJA A K, MATZUK M M.The mammalian ovary from genesis to revelation[J]. Endocr Rev, 2009, 30(6) : 624-712.